Last update 21 Nov 2024

An'ningpai changrongruan jiaonang

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
桃金娘科桉属/芸香科桔属/松科松属植物提取物, 桉柠蒎软胶囊
Target-
Mechanism-
Therapeutic Areas
Infectious DiseasesOtorhinolaryngologic DiseasesRespiratory Diseases+ [1]
Active Indication
SinusitisAcute BronchitisAcute sinusitis+ [2]
Inactive Indication-
Originator Organization
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
Active Organization
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (28 Aug 2020),
Sinusitis
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with An'ningpai changrongruan jiaonang
NCT04511897 / Unknown statusPhase 4IIT
Efficacy and Safety of An'Ningpai Enteric Soft Capsuleson in Stable Non-CF Bronchiectasis With Hypersecretion: a Open-label Randomized Controlled Trial
100 Clinical Results associated with An'ningpai changrongruan jiaonang
Login to view more data
100 Translational Medicine associated with An'ningpai changrongruan jiaonang
Login to view more data
100 Patents (Medical) associated with An'ningpai changrongruan jiaonang
Login to view more data
100 Deals associated with An'ningpai changrongruan jiaonang
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sinusitis
CN
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
28 Aug 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute BronchitisIND Approval
CN
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
02 Jan 2024
Acute sinusitisIND Approval
CN
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
02 Jan 2024
Bronchitis, ChronicIND Approval
CN
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
02 Jan 2024
Chronic sinusitisIND Approval
CN
Beijing Jiu He Pharmaceutical Ltd.Beijing Jiu He Pharmaceutical Ltd.
02 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free